Volume -
3 , - : 47-51 |
Back to browse issues page
Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:
Effect of Oral Menthol on Antioxidant Status of Polycystic Ovarian Syndrome-Induced Wister Rats. 3 https://doi.org/10.58209/gmjm.4.2.47
URL: http://daneshafarand.org/article-1-250-en.html
URL: http://daneshafarand.org/article-1-250-en.html
Abstract: (1371 Views)
Aims: Polycystic ovarian syndrome has been related to dyslipidemia and suppression of antioxidant status. However, novel agents such as menthol can be an efficient strategy for alleviation of this syndrome. This study was conducted to evaluate the effects of different levels of menthol on blood biochemical parameters and antioxidant status in polycystic ovarian syndrome-induced Wistar rats.
Materials & Methods: In this experimental study, 50 Wistar rats were used in 5 groups; healthy (negative control), polycystic ovarian syndrome that did not receive any menthol (positive control), and polycystic ovarian syndrome that received 2- (PCOS-2), 4- (PCOS-4) and 6mg/kg of body weight of menthol (PCOS-6). To induce the polycystic ovarian syndrome, 5mg of estradiol valerate was administrated. At the end of the trial session, blood samples were taken to evaluate plasma concentrations of glucose, insulin, total cholesterol, triglycerides, HDL-C, LDL-C, ferric-reducing ability of plasma (FRAP), advanced oxidation protein product (AOPP) and total oxidation status (TOS).
Findings: Induction of polycystic ovarian syndrome increased glucose, insulin, total cholesterol, triglycerides, LDL-C, FRAP, AOPP and TOS, and decrease HDL-C. The use of menthol especially in higher levels improved the mentioned parameters. Polycystic ovarian syndrome also increased body weight and oral treatment of menthol helped to maintain the body weight.
Conclusion: Menthol improves antioxidant status in rats with polycystic ovarian syndrome. Thus, use of menthol is recommended for treatment of polycystic ovarian syndrome.
Materials & Methods: In this experimental study, 50 Wistar rats were used in 5 groups; healthy (negative control), polycystic ovarian syndrome that did not receive any menthol (positive control), and polycystic ovarian syndrome that received 2- (PCOS-2), 4- (PCOS-4) and 6mg/kg of body weight of menthol (PCOS-6). To induce the polycystic ovarian syndrome, 5mg of estradiol valerate was administrated. At the end of the trial session, blood samples were taken to evaluate plasma concentrations of glucose, insulin, total cholesterol, triglycerides, HDL-C, LDL-C, ferric-reducing ability of plasma (FRAP), advanced oxidation protein product (AOPP) and total oxidation status (TOS).
Findings: Induction of polycystic ovarian syndrome increased glucose, insulin, total cholesterol, triglycerides, LDL-C, FRAP, AOPP and TOS, and decrease HDL-C. The use of menthol especially in higher levels improved the mentioned parameters. Polycystic ovarian syndrome also increased body weight and oral treatment of menthol helped to maintain the body weight.
Conclusion: Menthol improves antioxidant status in rats with polycystic ovarian syndrome. Thus, use of menthol is recommended for treatment of polycystic ovarian syndrome.
Subject:
Biotechnology
| Rights and permissions | |
 |
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License. |